VRK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of VRK Antibodies for understanding the role of Vaccinia-related kinase (VRK) proteins. VRK Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VRK proteins are serine/threonine kinases that regulate cell cycle progression, DNA damage response, and transcriptional control. The involvement of VRK proteins in cellular processes makes them particularly relevant in cancer research and diseases associated with disrupted cell proliferation and survival. Research focused on VRK proteins continues to reveal new insights about their biological functions and potential therapeutic applications. Understanding VRK protein activity and regulation can lead to the development of novel treatment strategies. Investigating VRK protein expression patterns helps identify their roles in different tissue types and cellular conditions. VRK protein research contributes to expanding knowledge about cellular signaling pathways and their impact on disease progression. Santa Cruz Biotechnology monoclonal antibodies for VRK proteins enable researchers worldwide to advance scientific understanding of cellular regulation and disease mechanisms.